Cyclademol (1) was converted for the first time to 1-(4-hydroxy-3,3-dimethylcyclohexyl) ethanone (2) and 4-(1-hydroxyethyl)-2,2-dimethylcyclohexanol (3) with 31.2 and 15.1% yields by Aspergillus niger and Neurospora crassa, respectively. The resulting metabolite structures were established by FT-IR, MS and NMR spectroscopic studies, respectively. In addition, the in vitro antimicrobial activities of the substrates and metabolites were evaluated comparatively both by using agar dilution and microdilution methods. The minimum inhibitory concentrations (MIC) of the tested compounds against a panel of pathogenic bacterial strains ranged from 1000 -4000 µg/mL, whereas the MIC values against fungal strains were between 500 -1000 µg/mL.
Cyclademol [1-(3,3-dimethylcyclohexyl)ethanol] (1) is a monoterpene synthesized by treating dihydromyrcene with formic acid alone or with a carboxylic acid or water in the presence of a Lewis acid such as sulfuric acid or a sulfonic acid resin [1, 2] . It has a value in perfume industries due to its fragrance and pleasant odor [2] [3] [4] . In this present study, the biotransformation of 1 by 15 different microbial strains were carried out with the aim of producing new compounds for flavor and fragrance use, as well as antimicrobial agents. To the best of our knowledge this is the first report on the biotransformation of cyclademol and resulting metabolites. From pre-biotransformation screening experiment of 1, it was found that its biotransformation with A. niger NRRL 326 and N. crassa showed the formation of a fragrant compound. These biotransformation reactions were repeated on semi-preparative scale to elucidate the structures of the metabolites formed. The microbial transformation of 1 by A. niger NRRL 326 for 7 days afforded the metabolite 2; 1-(4-hydroxy-3,3-dimethylcyclohexyl) ethanone, by eluting with 25% (v/v) ethyl acetate in petroleum ether (60-80ºC) as seen in Figure 1 . The mass spectrum of the metabolite showed a molecular ion at m/z 170 corresponding to the molecular formula of C 10 H 18 O 2 . The IR spectrum displayed a broad absorption at 3422 cm -1 , indicating the presence of hydroxyl groups. The 13 C-NMR spectrum indicated a new low field hydroxyl-bearing carbon and carbonyl signals at δ C 75.9 and 211.6 ppm, respectively, whereas a corresponding carbon signal resonating at 28.6 ppm disappeared. This indicated that a hydroxyl group was inserted to the ring, whereas the hydroxyl group at the side chain was oxidized to a ketone group in cyclademol. The newly introduced hydroxyl group position was established by HMBC spectrum which indicated the connectivity of proton signal of the methyl group at 1.05 (3H, s, 10-CH 3 ) to the carbon signals at δ C 17.8 (C-9), 35.5 (C-3), 41.0 (C-2) and 75.9 (C-4) confirming the hydroxylation on C-4.
The biotransformation of 1 by N. crassa for 7 days yielded the metabolite 3, 4-(1-hydroxyethyl)-2,2-dimethylcyclo-hexanol, by eluting with 35% (v/v) ethyl acetate in petroleum ether (60-80°C) as seen in Figure 2 . The mass spectrum of 3 showed a molecular ion at m/z 172 corresponding to the molecular formula of C 10 H 20 O 2 . The IR spectrum showed carbonyl and hydroxyl group absorptions at 1703 and 3430 cm -1 , respectively. The 13 C-NMR spectrum indicated a new low field hydroxyl-bearing carbon signal at δ C 77.8 ppm, whereas a carbon signal resonated at 28.6 ppm, which was absent in the cyclademol skeleton. Consequently, this indicated that a new hydroxyl group was added to the cyclademol structure. The newly introduced hydroxyl group position was established by HMBC spectrum which showed the connectivity of proton signal of the methyl group at 1.03 (3H, s, 10-CH 3 The MIC values of the tested compounds against all bacterial strains ranged from 1000 to 4000 µg/mL, whereas the MIC values against fungal pathogenic strains were between 500 and 1000 µg/mL, suggesting rather moderate bioactivity levels. (1) All microorganisms were stored at -85°C (New Brunswick) in 15% glycerol and maintained on nutrient agar (Merck, 1.05450) and malt extract agar (Merck) slants at 4°C, respectively. They were sub cultured, prior to use for purity check.
Experimental

General Experimental Procedures: Cyclademol
General Culture Conditions:
The cultures were maintained and precultured on potato dextrose agar (PDA) slants at 5 o C and 25 o C, respectively [5, 6] . A medium for growing fungi used in biotransformation experiments was described in our previous study [7] .
In vitro Antimicrobial Activity: The antibacterial and antifungal activities of compounds were studied by using the agar diffusion method, according to the National Committee for Clinical Laboratory Standards [8] [9] [10] . Ampicillin and chloramphenicol were used as standard antibacterial agents, whereas amphotericin B and ketoconazole were used as standard antifungal agents.
Minimal Inhibitory Concentration:
The minimal inhibitory concentration (MIC) of the compounds was determined by the microdilution method using a 96 well plate, according to NCCLS [8] [9] [10] . The metabolite concentrations ranged from 4000 to 15.62 µg/mL, whereas concentrations of standard antimicrobial agents were between 0.04 and 40 µg/mL. Stock solutions of the test samples were prepared up to 10% (v/v) dimethyl sulfoxide (Merck). 
Biotransformation by A. niger:
